The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations

VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians

(2013) Mohamed Hossam A. Shahin et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic

(2012) Andrew Y. Shuen et al.   CLINICAL BIOCHEMISTRY

Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction

(2012) Husam Qasim et al.   THROMBOSIS AND HAEMOSTASIS

More on: endoplasmic reticulum loop VKORC1 substitutions cause warfarin resistance but do not diminish gamma-carboxylation of the vitamin K-dependent coagulation factors

(2011) D. J. HARRINGTON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

(2011) Cathrine Mitchell et al.   PHARMACOGENOMICS

Optimization of warfarin dose by population-specific pharmacogenomic algorithm

(2011) A Pavani et al.   PHARMACOGENOMICS JOURNAL

The History of African Gene Flow into Southern Europeans, Levantines, and Jews

(2011) Priya Moorjani et al.   PLoS Genetics

Abraham's Children in the Genome Era: Major Jewish Diaspora Populations Comprise Distinct Genetic Clusters with Shared Middle Eastern Ancestry

(2010) Gil Atzmon et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

(2010) N. A. Limdi et al.   BLOOD

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment

(2010) M. WATZKA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The genome-wide structure of the Jewish people

(2010) Doron M. Behar et al.   NATURE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations

(2008) Stuart A. Scott et al.   AMERICAN JOURNAL OF HUMAN GENETICS

VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals

(2008) E. Aklillu et al.   BLOOD

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Oral anticoagulants: Pharmacogenetics

(2008) Giovanna D’Andrea et al.   BLOOD REVIEWS

Establishment of a biobank and pharmacogenetics database of African populations

(2008) Alice Matimba et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

VKORC1polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS

Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS